Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nephro Care IndiaNSE:NEPHROCARE +2.29%48 Days Payable is 378.23 as of Mar. 2026, which is 494% above its 10-year median of 63.70. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Nephro Care India ranks better than 78.3% on this metric.
The historical rank and industry rank for Nephro Care India's Days Payable or its related term are showing as below:
NSE:NEPHROCARE'
s Days Payable Range Over the Past 10 Years
Min: 41.53 Med: 63.7 Max: 134.16
Current: 134.16
During the past 6 years, Nephro Care India's highest Days Payable was 134.16. The lowest was 41.53. And the median was 63.70.
NSE:NEPHROCARE's Days Payable is ranked better than 78.3% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 58.16
vs NSE:NEPHROCARE: 134.16
Nephro Care India's Days Payable
increased
from Sep. 2025 (0.00) to Mar. 2026 (378.23).
It may suggest that Nephro Care Indiadelayed paying its suppliers.
The historical data trend for Nephro Care India's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEPHROCARE vs HCA, THC, EHC: Days Payable Comparison
For the Medical Care Facilities subindustry, Nephro Care India's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's Days Payable distribution charts can be found below:
* The bar in red indicates where Nephro Care India's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Nephro Care India's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephro Care India (NSE:NEPHROCARE) has a Days Payable of 378.23 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nephro Care India and its competitors. This is 494% above median its historical median of 63.70. Over the past decade, Nephro Care India's Days Payable has ranged from 41.53 to 134.16. According to the industry distribution chart, Nephro Care India ranks #133 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 21.7%.
Is Nephro Care India's Days Payable too high?
Nephro Care India's current Days Payable of 378.23 is 494% above median its 10-year median of 63.70. Over the past 10 years, this metric has ranged from a low of 41.53 to a high of 134.16. The Healthcare Providers & Services industry median Days Payable is 58.16. Nephro Care India's value of 378.23 is 550.3% above this industry median. Based on the distribution chart, Nephro Care India ranks #133 out of 613 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nephro Care India ranks #133 out of 613 companies for Days Payable. This places Nephro Care India in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.16. Nephro Care India's value of 378.23 is 550.3% above this benchmark. Historically, Nephro Care India's own Days Payable has ranged from 41.53 to 134.16 over the past decade. While the company's 10-year median is 63.70 vs. the industry median of 58.16, Nephro Care India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.16, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nephro Care India's current Days Payable of 378.23 is 550.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nephro Care India and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nephro Care India's current Days Payable is 378.23, which is 494% above median its own 10-year median of 63.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current Days Payable of 378.23. The current Days Payable is 378.23, which is 494% above median its 10-year median of 63.70 and 550.3% above the Healthcare Providers & Services industry median of 58.16. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current Days Payable is 378.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score
Get the complete analysis for NSE:NEPHROCARE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEPHROCARE has been successfully added to your 
